BACKGROUND The epidemiology of the hepatitis B virus (HBV) infection in psychiatric patients from developing countries is poorly studied. Therefore, we sought to determine the frequency of HBV surface antigen (HBsAg) and HBV surface antibody (HBsAb) serological markers of HBV infection in a population of patients of a psychiatric hospital in Durango City, Durango, Mexico, and to determine wheth...

BACKGROUND Hepatitis B virus (HBV) vaccination is a well-known, safe and effective way for protection against HBV infection; however, non-responders remain susceptible to infection with HBV. This is so important in patients with any kind of chronic liver disease, especially chronic hepatitis C virus (HCV) patients in whom acute HBV infection may lead to decompensation of liver disease. Some of ...

conclusion hepatitis b vaccination of all nonimmune healthcare workers and measuring hbsab after vaccination can reduce the risk of nosocomial transmission of hbv to medical staff. furthermore, the risk of blood-borne disease transmission can be reduced by educating medical personnel on effective methods of reducing the risk of nssis as well as taking appropriate measures when nssis occur. resu...

Abstract Background and Aims Patients with end-stage renal disease (ESRD) frequently present serologic evidence of previous contact hepatitis B virus (HBV). Although uncommon, HBV reactivation after kidney transplantation (KT) may cause serious complications adverse outcomes in these patients. However, data regarding risk factors for are still scarce. This study aims to describe a cohort patien...

background: generally, a number of people with î²-thalassemia are susceptible to hbv since they receive multiple blood transfusions. these people have high infection rates despite vaccination against hbv. in this study, we explore the seroprevalence and risk factors of hbv infection in thalassemic patients who reside in ardabil. materials and methods: hospital in ardabil. patients' demographic ...

OBJECTIVE To study the changing trends of hepatitis B markers tested at Aga Khan University Hospital clinical laboratory according to the internationally recognised classification of hepatitis B profile. METHODS The retrospective study involved analysis of laboratory records of hepatitis B profiles of all patients collected from January 2001 to December 2008 at the Aga Khan University Hospita...

BACKGROUND Egypt is considered a region of the intermediate prevalence of hepatitis B virus (HBV) infection (4.5%). Seroprotection is assured when hepatitis B surface antibody (HBsAb) levels are ≥ 10 mIU/mL. Our study aimed to evaluate and compare the long-term immunogenicity and efficacy of the recombinant hepatitis B (HB) vaccine. METHODS A cross-sectional study was done for children aged f...

Background: Hepatitis B virus potentially accelerates graft rejection and mortality in renal transplantation population. Vaccination of graft candidates without prior immunization against HBV seems essential before transplantation but some candidates of transplantation have not received HBV vaccine at the time of receiving graft. We aimed to evaluate immunogenicity of ...

Background: Hepatitis B virus is known as one of the most common pathogen in the world. 350 million people are chronic carrier in the world and more than 3/4 hepatitis B virus infection are in Middle East and Africa. Various statistics of this infection has been reported in Iran. Since vaccination plan of 1989 born not only in Zabol but through Iran, will be performed and there is no exact info...